Clinics in New Hampshire
By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified
What New Hampshire law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.
New Hampshire at a glance
- Pharmacy regulator
- New Hampshire Board of Pharmacy (Office of Professional Licensure and Certification)
- 503A framework
- Follows the federal 503A framework
- Telehealth prescribing
- Regulatory: Telehealth allowed
- Asynchronous prescribing
- Regulatory: Async unclear
- Compounded GLP-1 access
- Regulatory: Compounded GLP-1 limited
Verified clinics serving New Hampshire
No verified clinics serving New Hampshire are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.
Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.
Run a pharmacy, clinic, or telehealth service? Apply for a listing.
Peptide access rules in New Hampshire
Yes. A New Hampshire resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a New Hampshire-licensed prescriber, including by telemedicine; RSA 329:1-d treats an out-of-state physician treating a New Hampshire patient by telemedicine as practicing medicine in New Hampshire, so a New Hampshire license is required. A compounded peptide is available when it is eligible under federal 503A rules and dispensed by a pharmacy permitted by the New Hampshire Board of Pharmacy, part of the Office of Professional Licensure and Certification; out-of-state pharmacies need a New Hampshire mail-order (nonresident) pharmacy registration under RSA 318:37. [1] [2] [3] [4] [5] [6] [7]
Compounded GLP-1 access in New Hampshire
A telehealth GLP-1 program serving New Hampshire needs a New Hampshire-licensed prescriber under RSA 329:1-d and a pharmacy with a New Hampshire mail-order registration. [2] [4] [8]
Research use only sellers in New Hampshire
RSA chapter 318 limits dispensing of prescription drugs to permitted pharmacies and licensed practitioners, so sellers of "research use only" injectable peptides to New Hampshire consumers are not lawful dispensers in the state. [3] [9]
New Hampshire notes on specific peptides
- Semaglutide: Available branded by prescription from a New Hampshire-licensed prescriber, including by telemedicine under RSA 329:1-d. Compounded semaglutide is limited to the federal patient specific exception since April 22, 2025. [2] [8]
How to check a clinic in New Hampshire
- Confirm the prescribing clinician's license with the New Hampshire medical or nursing board.
- Ask which pharmacy compounds or dispenses the peptide and check it in the New Hampshire Board of Pharmacy (Office of Professional Licensure and Certification) license lookup. [1] [3] [4] [5] [6] [7]
- Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
- Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in New Hampshire. [3] [9]
Common questions in New Hampshire
Can I get a GLP-1 prescription in New Hampshire through telemedicine?
Yes, from a New Hampshire-licensed physician or physician assistant. RSA 329:1-d limits telemedicine prescribing authority to New Hampshire licensees. Semaglutide and tirzepatide are not controlled substances, so the in-person exam rules for controlled drugs do not apply. [2]
Can an out-of-state doctor treat me in New Hampshire by telemedicine?
Only with a New Hampshire license. RSA 329:1-d treats an out-of-state physician providing telemedicine to a New Hampshire patient as practicing medicine in the state, apart from narrow physician-to-physician consultation. [2]
Sources
- [1]New Hampshire Board of Pharmacy (OPLC)
- [2]New Hampshire RSA 329:1-d, Telemedicine
- [3]New Hampshire RSA chapter 318, Pharmacists and pharmacies
- [4]New Hampshire RSA 318:37, Mail-order pharmacies: registration required; compliance
- [5]New Hampshire Board of Pharmacy laws and rules (Ph 100 to Ph 2600)
- [6]N.H. Code Admin. R. Ph 404, Standards for compounding and dispensing sterile and non-sterile pharmaceuticals (in Ph 100 to Ph 2600)
- [7]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [8]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
- [9]21 U.S.C. 331, Prohibited acts